Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

Affiliations

• ¹ BioNTech, Mainz, Germany.
• ² South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
• ³ School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
• ⁴ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
• ⁵ Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United States.
• ⁶ Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.